PCE Regional Insights: Diabetes

Enhancing Care for Patients With Type 2 Diabetes: A Focus on Incretin-Based Therapies

PCE Regional Insights: Enhancing Care for Patients With Type 2 Diabetes: A Focus on Incretin-Based Therapies is designed to help nurse practitioners and physician assistants understand the role of the incretin system in maintaining a healthy glycemic state; how incretin-based therapies differ from other T2DM medications; and how to incorporate incretin-based therapy into the management of appropriate patients with T2DM.

Learning Objectives
After completing this activity, participants will be better able to:

Describe the physiology of glucose metabolism, including the role of incretins in the first-phase insulin response in patients with T2DM
Explain the role of ß-cell health in the pathophysiology of diabetes
Design a plan that incorporates incretin-based therapies as part of optimal management of appropriate patients with T2DM
Apply specific strategies to increase adherence of patients to optimal glycemic therapy

Dwight M. Deter, PA-C, CDE
Clinical Assistant Professor
School of Allied Health Sciences
Texas Tech University Health Sciences Center
Southwest Endocrine Consultants
El Paso, Texas

Charles F. Shaefer Jr, MD
Assistant Clinical Professor of Medicine
Medical College of Georgia
Augusta, Georgia

Target Audience
Nurse practitioners and physician assistants

Brought to you by

Accreditation Information
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is provided for 1.0 contact hour under ANCC criteria.

Provided for 1.2 contact hours under Iowa Provider #78. Provider approved by the California Board of Registered Nursing, Provider #13699 for 1.2 contact hours.
This program has been reviewed and is approved for a maximum of 1 hour of AAPA Category I CME credit by the Physician Assistant Review Panel. Approval is valid for 1 year from the issue date of January 15, 2010. Participants may submit the self-assessment at any time during that period.

This program was planned in accordance with AAPA's CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.

This program was supported by an educational grant from Bristol-Myers Squibb and AstraZeneca.

The estimated time to complete this activity is 1 hour.

Release date: January 15, 2010
Expiration date: January 15, 2011

Disclosures
All faculty and planners participating in continuing education activities sponsored by the University of Nebraska Medical Center College of Nursing Continuing Nursing Education are expected to disclose to the audience any significant support or substantial relationship(s) with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Please note that this activity may refer to use of products for a purpose other than which they were approved by the Food and Drug Administration.

Faculty Disclosures
Mr Deter: speakers bureau: Bristol-Myers Squibb, Daiichi Sankyo Company, GlaxoSmithKline, sanofi-aventis.
Dr Shaefer: educator/consultant: sanofi-aventis; educator: Amylin-Lilly, Daiichi Sankyo Company, Forest Pharmaceuticals, Inc., Novartis, Pfizer Inc, Takeda Pharmaceuticals Company.

Disclaimer
The opinions or views expressed in this continuing education activity are those of the faculty and do not necessarily reflect the opinions or recommendations of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education, American Academy of Physician Assistants, Continuing Education Alliance, Practicing Clinicians Exchange, Bristol-Myers Squibb, or AstraZeneca.

Accredited status as a provider of continuing nursing education refers only to the University of Nebraska Medical Center College of Nursing Continuing Nursing Education continuing education activities, and does not imply UNMC or American Nurses Credentialing Center’s Commission on Accreditation endorsement of any commercial supporters.

Please note that while the University of Nebraska Medical Center College of Nursing Continuing Nursing Education is an ANCC accredited organization, this does not imply endorsement by the UNMC or ANCC of any commercial products affiliated with this activity.

© 2010 Practicing Clinicians Exchange. All Rights Reserved. BPCE53109